Trial Profile
A Phase 1, Evaluation of Transgenic Lymphocyte Immunization Vaccine in Subjects With Prostate Adenocarcinoma
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs CB 1001 (Primary)
- Indications Prostate cancer
- Focus Adverse reactions
- 13 Oct 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 13 Oct 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 27 Sep 2005 New trial record.